Overview
Toshihito Suda practices practicing medicine in Tokyo, Japan.
Their clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC) and PIK3CA-Related Overgrowth Spectrum.
They are actively involved in clinical research, co-authoring 9 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Toshihito Suda
Is Toshihito Suda a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Toshihito Suda is classified as an Experienced expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Toshihito Suda participate in research or clinical trials?
Yes. Toshihito Suda has published 9 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Toshihito Suda's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- PIK3CA-Related Overgrowth Spectrum